BioWorld-International-2011-05-18
Parasite Study Challenges Old Thinking on Inflammation
Clavis, Translational Therapeutics in Antiviral Drug-for-Equity Deal
Clavis Pharma ASA has gained a small equity stake in Translational Therapeutics Inc. in return for out-licensing its modified version of the antiviral drug ribavirin for applications in cancer. (BioWorld International)

